Learn more about Monash Health’s Haematology team.
Professor Jake Shortt
BMedSc, Otago (Distinction); MB ChB, Otago (Distinction); FRACP; FRCPA; PhD, Melbourne.
Prof Jake Shortt is a clinical and laboratory Haematologist with subspecialty interests in malignant haematology – particularly leukaemia, lymphoma, myelodysplasia and myeloma. He is the clinical lead at Monash Health for chronic myeloid leukaemia, myelodysplasia and T-cell lymphoma and serves as a Principal Investigator on phase 1-4 clinical trials in these disease areas.
Prof Shortt is co-appointed to Monash University as the Head of Haematology Research within the Department of Medicine at the School of Clinical Sciences and is an Adjunct Clinical Professor at the University of Melbourne in the Sir Peter MacCallum Department of Oncology.
He heads the ‘Blood Cancer Therapeutics Laboratory’ in the Monash Health Translation Precinct, seeking to discover new blood cancer treatments and bring them to the clinic. His research program is supported by an NHMRC Investigator Grant and funding from the Cancer Council of Victoria (CCV) and the US Leukaemia and Lymphoma Society. His laboratory is also generously supported by philanthropic donations from the Bode Family and Dr Alexander Baxter.